Zevra Therapeutics, Inc. is rated a Buy, delivered robust FY25 results, with 350% revenue growth to $106.5M. Learn more about ZVRA stock here.

Good morning, and welcome to OppFi's Fourth Quarter 2025 Earnings Call. Today, our Executive Chairman and CEO, Todd Schwartz. and CFO Pam Joh ...

None ...

Here’s the inside story on the acceleration, braking, and handling performance of the granddaddy Corvette, the all-wheel-drive ZR1X.

Engineers leverage both device-specific and tool-level data to identify a process “sweet spot.” Tight, frequent tool-to-tool matching enables greater yield and fab flexibility. Machine learning helps ...

Jensen Huang says AI is infrastructure. Here is why that matters for power, chips, AI factories, Physical AI, agentic AI in ...

Engine struggles, poor timing and management churn leave Silverstone-based team starting campaign with underpowered and dangerous car ...

The Cross Country flagship of Volvo’s smallest and fastest-ever production car is a strange ...

Patients who have had a VUS through NGS that is predicted to cause abnormal splicing. Patients who want to prepare for prenatal/pre-implantation diagnosis and for predictive testing for individuals at ...

House Bill 1706, sponsored by Deputy Speaker Jason Zachary, R-Knoxville, establishes a Class A misdemeanor for an illegal alien to operate a commercial motor vehicle (CMV) in Tennessee. It would also ...

Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.